Global Anesthesia Drug Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • ID: 4412845
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4
Global Anaesthesia Drug Market Showing Steady Growth Forecast at CAGR of 3% During 2016- 2023

FEATURED COMPANIES

  • Abbot Laboratories
  • Baxter International Inc
  • Eisai Co Ltd
  • Hikma Pharmaceuticals Plc
  • Mylan Nv
  • Pfizer
  • MORE

The anesthesia drug market is developing and expanding at a significant pace on the global scenario owing to enhancing utility of the anesthesia drugs in the surgeries and transplants considering the medical sector.  The anesthesia drug has made a huge impact in the innovation and growth of the medical sector and mainly in the branches of medical sector which includes surgeries and treatment of chronic diseases such as cardiovascular diseases. The anesthesia drug market is mainly driven by the rising healthcare expenditure in the regions such as North America and Europe.. The rising utility of inhalation which is a route of administration is acting as a key trend in the Anesthesia drug market. The presence of various clinical research labs in North America and Europe working towards the introduction of new anesthesia drugs are also boosting the anesthesia drug market. The lack of medical facilities in the underdeveloped nations and presence of few of experienced medical experts and surgeons are hindering the growth of the market.

The general anesthesia segment of the type segment is anticipated to be the dominating segment during the forecasted period of 2016-2023. The general anesthesia has its utility in various surgeries and treatment of diseases which mainly includes the cardiovascular, obesity and orthopedic surgeries on the global scenario. The product segment of the anesthesia drug market is anticipated to be the fastest growing segment due to the utility of the anesthetic drugs which mainly includes isoflurane, sevoflurane, Propofol, in the medical treatment and surgeries occurring in both the male and female body. These drugs also have their pivotal utility in the child delivery as they impact the female body by making it numb so that she doesn’t  feel the pain during or after surgery.

Geographically, the anesthesia drug market is divided mainly into regions such as North America, Europe, Asia-pacific and rest of the world. The Asia-pacific region is anticipated to witness the fastest growth in the forthcoming years owing to the rising number of hospitals & diagnostic centers and, framework of healthcare reforms and policies (mainly by the countries such as China and India) to expand access considering health care facilities for the common public. The enhancing demand of Propofol is mainly in the market of United States and Canada. The enhancing focus of large number of playershaving presence in the anesthesia drug market, works towards finding the new ways of administration, which includes topical and oral,are also supporting the growth of the market in the North American region. The medical experts’ union states that the rising demand considering child delivery will directly impact the growth of anesthesia drug market. The European region is also expected to have growth opportunities in the anesthesia drug market due to supportive norms and policies considering the healthcare mainly in the United Kingdom and Germany, and presence of many clinical research labs working towards the innovation and development of new anesthetic drugs in the European market.

The Major organizations operating in the anesthesia drug market includes Piramal, Novartis, Mylan NV, Hospira Inc, ABBOT laboratories and Baxter International PLC.



Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbot Laboratories
  • Baxter International Inc
  • Eisai Co Ltd
  • Hikma Pharmaceuticals Plc
  • Mylan Nv
  • Pfizer
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology
 
2. Market Overview
2.1. Global Anesthesia Drug Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Total Market Analysis
2.4.1. Top 5 Findings
2.4.2. Top 5 Opportunity Markets
2.4.3. Top 5 Companies
2.4.4. Top 3 Competitive Strategies
2.5. Estimation Analysis
2.6. Strategic Analysis
2.6.1. Investment Vs. Adoption Model
2.6.2. 360 Degree Industry Analysis
2.6.3. Porters 5 Force Model
2.6.4. See-Saw Analysis
2.6.5. Gap Analysis
2.6.6. Patent Analysis
2.6.7. Pricing Analysis
2.6.8. Consumer Analysis And Key Buying Criteria
2.7. Competitive Analysis
2.7.1. Key Strategies & Analysis
2.7.2. Market Share Analysis & Top Company Analysis
2.8. Strategic Recommendations & Key Conclusions
2.8.1. Investment Opportunities By Regions
2.8.2. Opportunities in Emerging Applications
2.8.3. Investment Opportunity in Fastest Growing Segment
 
3. Market Determinants
3.1. Market Drivers
3.1.1. Rising Number of Surgeries
3.1.2. Evolution of New Sedative 7 Anesthetic Drugs
3.1.3. Decrease in the Price of Newly Invented Drugs
3.1.4. Reduction in the Recovery Time Subsequently Surgery
3.2. Market Restraints
3.2.1. Side Effects of Anesthesia Drugs
3.2.2. Availability of Skilled Anesthetics Experts
3.3. Market Opportunities
3.3.1. Rising Private & Public Health Insurers
3.3.2. Availability in Generic Form & Low Cost Products
3.4.   Market Challenges
3.4.1. Impact On Narrow Range of Ailments
 
4. Market Segmentation
4.1. Global Anesthesia Drug Market By Type
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4.  Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global General Anesthesia Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.1.3. Key Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.2. Global Spinal Anesthesia Market
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.2.3. Key Players & Key Products
4.1.5.2.4. Key Conclusions
4.1.5.3. Global Peripheral Nerve Block Market
4.1.5.3.1. Adoption Scenario & Market Determinants
4.1.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.3.3. Key Players & Key Products
4.1.5.3.4. Key Conclusions
4.1.5.4. Global Saddle Block Anesthesia Market
4.1.5.4.1. Adoption Scenario & Market Determinants
4.1.5.4.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.4.3. Key Players & Key Products
4.1.5.4.4. Key Conclusions
4.1.5.5. Global Interscalene Block Market
4.1.5.5.1. Adoption Scenario & Market Determinants
4.1.5.5.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.5.3. Key Players & Key Products
4.1.5.5.4. Key Conclusions
4.1.5.6. Global Iv Regional Anesthesia Market
4.1.5.6.1. Adoption Scenario & Market Determinants
4.1.5.6.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.6.3. Key Players & Key Products
4.1.5.6.4. Key Conclusions
4.2. Global Anesthesia Drug Market By Routes of Administration
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4.  Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Injection Market
4.2.5.1.1. Application
4.2.5.1.2. Adoption Scenario & Market Determinants
4.2.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.4. Key Players & Key Products
4.2.5.1.5. Key Conclusions
4.2.5.2. Global Inhalation Market
4.2.5.2.1. Application
4.2.5.2.2. Adoption Scenario & Market Determinants
4.2.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.4. Key Players & Key Products
4.3. Global Anesthesia Drug Market By Product
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4.  Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Global Propofol Market
4.3.5.1.1. Application
4.3.5.1.2. Adoption Scenario & Market Determinants
4.3.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.1.4. Key Players & Key Products
4.3.5.1.5. Key Conclusions
4.3.5.2. Global Sevoflurane Market
4.3.5.2.1. Application
4.3.5.2.2. Adoption Scenario & Market Determinants
4.3.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.2.4. Key Players & Key Products
4.3.5.2.5. Key Conclusions
4.3.5.3. Global Desflurane Market
4.3.5.3.1. Application
4.3.5.3.2. Adoption Scenario & Market Determinants
4.3.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.3.4. Key Players & Key Products
4.3.5.3.5. Key Conclusions
4.3.5.4. Global Remifentanil Market
4.3.5.4.1. Application
4.3.5.4.2. Adoption Scenario & Market Determinants
4.3.5.4.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.4.4. Key Players & Key Products
4.3.5.4.5. Key Conclusions
4.3.5.5. Global Midazolam Market
4.3.5.5.1. Application
4.3.5.5.2. Adoption Scenario & Market Determinants
4.3.5.5.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.5.4. Key Players & Key Products
4.3.5.5.5. Key Conclusions
4.3.5.6. Global Dexmedetomidine Market
4.3.5.6.1. Application
4.3.5.6.2. Adoption Scenario & Market Determinants
4.3.5.6.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.6.4. Key Players & Key Products
4.3.5.6.5. Key Conclusions
4.3.5.7. Global Others Market
4.3.5.7.1. Application
4.3.5.7.2. Adoption Scenario & Market Determinants
4.3.5.7.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.7.4. Key Players & Key Products
4.3.5.7.5. Key Conclusions
 
5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Merger & Acquisition
5.1.2. List of Joint Venture
5.1.3. List of Product Launches
5.1.4. List of Partnership
5.2. Top 10 Company Analysis
 
6. Geographical Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4.  Global Anesthesia Drug Market By Region
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Key Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Key Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Key Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Key Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Key Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Russia
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Key Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Key Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Key Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Key Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Key Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Key Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Key Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Key Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Key Players & Key Products
6.4.4.2.2.3. Key Conclusions
 
7. Company Profiles
7.1.  Abbot Laboratories
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Strategic Initiatives
7.1.4. Scot Analysis
7.1.5. Strategic Analysis
7.2. Astra Zeneca
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Strategic Initiatives
7.2.4. Scot Analysis
7.2.5. Strategic Analysis
7.3. Baxter International Inc
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Strategic Initiatives
7.3.4. Scot Analysis
7.3.5. Strategic Analysis
7.4. Boehringer Ingelheim
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Strategic Initiatives
7.4.4. Scot Analysis
7.4.5. Strategic Analysis
7.5. Eisai Co Ltd
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Strategic Initiatives
7.5.4. Scot Analysis
7.5.5. Strategic Analysis
7.6. Fresenius Se & Co Kgaa
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Strategic Initiatives
7.6.4. Scot Analysis
7.6.5. Strategic Analysis
7.7. Hikma Pharmaceuticals Plc
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Strategic Initiatives
7.7.4. Scot Analysis
7.7.5. Strategic Analysis
7.8. Hospira Inc
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Strategic Initiatives
7.8.4. Scot Analysis
7.8.5. Strategic Analysis
7.9. Mylan Nv
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Strategic Initiatives
7.9.4. Scot Analysis
7.9.5. Strategic Analysis
7.10. Novartis
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Strategic Initiatives
7.10.4. Scot Analysis
7.10.5. Strategic Analysis
7.11. Par Pharmaceuticals Companies Inc
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Strategic Initiatives
7.11.4. Scot Analysis
7.11.5. Strategic Analysis
7.12. Piramal
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Strategic Initiatives
7.12.4. Scot Analysis
7.12.5. Strategic Analysis
7.13. Pfizer
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Strategic Initiatives
7.13.4. Scot Analysis
7.13.5. Strategic Analysis
7.14. Roche
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Strategic Initiatives
7.14.4. Scot Analysis
7.14.5. Strategic Analysis
7.14.6.
7.15. Sas Institute, Inc.
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Strategic Initiatives
7.15.4. Scot Analysis
7.15.5. Strategic Analysis
 
List of Tables
1. Global Anesthesia Drug Market By Type 2014-2023 ($ Million)
2. Global Generaal Anesthesia Market By Geography 2014-2023 ($ Million)
3. Global Spinal Anesthesia Market By Geography 2014-2023 ($ Million)
4. Global Peripheral Nerve Block Market By Geography 2014-2023 ($ Million)
5. Global Saddle Block Anesthesia Market By Geography 2014-2023 ($ Million)
6. Global Interscalene Block Anesthesia Market By Geography 2014-2023 ($ Million)
7. Global Iv Regional Anesthesia Market By Geography 2014-2023 ($ Million)
8. Global Anesthesia Drug Market By Routes of Administration 2014-2023 ($ Million)
9. Global Injection Market By Geography 2014-2023 ($ Million)
10. Global Inhalation Market By Geography 2014-2023 ($ Million)
11. Global Anesthesia Drug Market By Product 2014-2023 ($ Million)
12. Global Anesthesia Drug Market in Propofol By Geography 2014-2023 ($ Million)
13. Global Anesthesia Drug Market Sevoflurane By Geography 2014-2023 ($ Million)
14. Global Desflurane Market By Geography 2014-2023 ($ Million)
15. Global Remifentanil Market By Geography 2014-2023 ($ Million)
16. Global Midazolam Market By Geography 2014-2023 ($ Million)
17. Global Dexmedetomidine Market By Geography 2014-2023 ($ Million)
18. Global Others Market By Geography 2014-2023 ($ Million)
19. Global Automotive Market By Geography 2014-2023 ($ Million)
20. North America Anesthesia Drug Market 2014-2023 ($ Million)
21. Europe Anesthesia Drug Market 2014-2023 ($ Million)
22. Asia Pacific Anesthesia Drug Market 2014-2023 ($ Million)
23. Rest of the World Anesthesia Drug Market 2014-2023 ($ Million)
 
List of Figures
1. Global Anesthesia Drug Market By General Anesthesia 2014-2023 ($ Million)
2. Global Anesthesia Drug Market By Spinal Anesthesia 2014-2023 ($ Million)
3. Global Anesthesia Drug Market By Peripheral Nerve Block 2014-2023 ($ Million)
4. Global Anesthesia Drug Market By Saddle Block Anesthesia 2014-2023 ($ Million)
5. Global Anesthesia Drug Market By Interscalene Block 2014-2023 ($ Million)
6. Global Anesthesia Drug Market By Iv Regional Anesthesia 2014-2023 ($ Million)
7. Global Anesthesia Drug Market By Injection 2014-2023 ($ Million)
8. Global Anesthesia Drug Market By Inhalation 2014-2023 ($ Million)
9. Global Anesthesia Drug Market By Propofol 2014-2023 ($ Million)
10. Global Anesthesia Drug Market By Sevoflurane 2014-2023 ($ Million)
11. Global Anesthesia Drug Market By Desflurane 2014-2023 ($ Million)
12. Global Anesthesia Drug Market By Remifantanil 2014-2023 ($ Million)
13. Global Anesthesia Drug Market By Midazolam 2014-2023 ($ Million)
14. Global Anesthesia Drug Market By Dexmedetomidine 2014-2023 ($ Million)
15. Global Anesthesia Drug Market By Others 2014-2023 ($ Million)
16. United States (U.S.) Anesthesia Drug Market 2014-2023 ($ Million)
17. Canada Anesthesia Drug Market 2014-2023 ($ Million)
18. United Kingdom (Uk) Anesthesia Drug Market 2014-2023 ($ Million)
19. France Anesthesia Drug Market 2014-2023 ($ Million)
20. Germany Anesthesia Drug Market 2014-2023 ($ Million)
21. Russia Anesthesia Drug Market  2014-2023 ($ Million)
22. Roe Anesthesia Drug Market  2014-2023 ($ Million)
23. India Anesthesia Drug Market  2014-2023 ($ Million)
24. China Anesthesia Drug Market Mt 2014-2023 ($ Million)
25. Japan Anesthesia Drug Market  2014-2023 ($ Million)
26. Australia Anesthesia Drug Market  2014-2023 ($ Million)
27. Roapac Anesthesia Drug Market  2014-2023 ($ Million)
28. Latin America Anesthesia Drug Market  2014-2023 ($ Million)
29. Mena Anesthesia Drug Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbot Laboratories
  • Astra Zeneca
  • Baxter International Inc
  • Boehringer Ingelheim
  • Eisai Co Ltd
  • Fresenius Se & Co Kgaa
  • Hikma Pharmaceuticals Plc
  • Hospira Inc
  • Mylan Nv
  • Novartis
  • Par Pharmaceuticals Companies Inc
  • Pfizer
  • Piramal
  • Roche
  • Sas Institute, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll